查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589706

电子给药系统市场：按类型、适应症、分销管道划分 - 全球预测 2025-2030 年

Electronic Drug Delivery System Market by Type (Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens), Indication (Asthma & COPD, Cardiovascular Disease, Diabetes), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

电子给药系统市场2023年估值为113.5亿美元，预计到2024年将达到125.6亿美元，复合年增长率为11.43%，预计到2030年将达到242.2亿美元。

电子药物输送系统 (EDDS) 代表了医疗保健领域的一种变革性方法，它透过整合电子和药物传输机制来优化准确性、计时和患者依从性。 EDDS 的范围和定义涵盖了广泛的设备，例如输液帮浦、自动注射器和吸入器，它们利用电子元件来提高给药的准确性和有效性。对 EDDS 的需求源于对患者特定用药方案的需求不断增加、提高依从性的需要以及慢性疾病的扩散，其中精确的药物传递至关重要。 EDDS 的应用涵盖许多治疗领域，包括糖尿病、疼痛管理、肿瘤学和神经病学，最终用途遍及医院、居家医疗机构和专科诊所。根据市场洞察，技术进步和对微创设备不断增长的需求是成长的主要影响因素。此外，老年人口的成长和个人化医疗的推动提供了巨大的潜在机会。抓住这些机会的建议包括投资研发以提高设备连接性和易用性，以及新兴国家的打入市场策略。然而，高成本、严格的监管核准以及潜在的网路安全威胁等限制因素给市场扩张带来了挑战。克服这些挑战需要明确关注降低成本、合规性和强有力的网路安全措施。创新和研究成熟的领域之一是人工智慧 (AI) 和物联网的集成，以增强即时资料分析并改进设备功能。 EDDS 市场的特点是技术快速发展和竞争压力，需要不断创新和策略伙伴关係才能实现永续成长。总之，对于希望在不断发展的 EDDS 环境中发展的公司来说，在应对成本和监管环境挑战的同时拥抱技术整合至关重要。

主要市场统计
基准年[2023] 113.5亿美元
预测年份 [2024] 125.6亿美元
预测年份 [2030] 242.2亿美元
复合年增长率（%） 11.43%

市场动态：快速发展的电子给药系统市场的关键市场洞察

供需的动态交互作用正在改变电子给药系统市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 目标疾病盛行率增加
    • 主要市场有利的赎回情况
    • 技术和设计的进步
  • 市场限制因素
    • 对替代药物传递方法的偏好和潜在的错误
  • 市场机会
    • 对生技药品和单株抗体的需求增加
    • 新兴市场的成长机会
  • 市场挑战
    • 新兴国家不利的报销结构

波特五力策略工具引领电子给药系统市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解电子给药系统市场的外部影响

外部宏观环境因素在塑造电子给药系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解电子给药系统市场的竞争格局

对电子药物输送系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵电子给药系统市场供应商的绩效评估

FPNV 定位矩阵是评估电子给药系统市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

制定电子给药系统市场成功之路的策略分析与建议

对于旨在加强在全球市场的影响力的公司来说，对电子药物输送系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大目标疾病的传播
      • 主要市场有利的赎回情况
      • 技术和设计的进步
    • 抑制因素
      • 对替代药物传递方法的偏好和潜在的错误
    • 机会
      • 对生技药品和单株抗体的需求增加
      • 新兴市场的成长机会
    • 任务
      • 新兴国家不利的报销结构
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章电子给药系统市场：依类型

  • 电子自动注射器
  • 电子吸入器
  • 电子注射笔
  • 穿戴式电子输液泵

第七章电子给药系统市场（依适应症）

  • 气喘及慢性阻塞性肺病
  • 心血管疾病
  • 糖尿病
  • 多发性硬化症

第八章电子给药系统市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第九章美洲电子给药系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区电子给药系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲电子给药系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amgen, Inc.
  • Astrazeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Cane SPA
  • Debiotech SA
  • F.Hoffmann-La Roche, Ltd.
  • Findair SP. Z OO
  • Insulet Corporation
  • Medtronic PLC
  • Merck Group
  • Novo Nordisk A/S
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Vicentra BV
Product Code: MRR-432CBFF6F300

The Electronic Drug Delivery System Market was valued at USD 11.35 billion in 2023, expected to reach USD 12.56 billion in 2024, and is projected to grow at a CAGR of 11.43%, to USD 24.22 billion by 2030.

The Electronic Drug Delivery System (EDDS) represents a transformative approach in health care by integrating electronics with drug delivery mechanisms to optimize precision, timing, and patient compliance. The scope and definition of EDDS encompass a wide range of devices including infusion pumps, autoinjectors, and inhalers that utilize electronic components to improve accuracy and efficacy in drug administration. The necessity of EDDS arises from the increasing demand for patient-specific medication regimes, the need for improved compliance, and the burgeoning prevalence of chronic diseases where precise drug delivery is crucial. Applications of EDDS span across numerous therapeutic areas such as diabetes, pain management, oncology, and neurology, with end-use distributed among hospitals, home care settings, and specialty clinics. Market insights reveal that technological advancements and the rising demand for minimally invasive devices are key influencing factors for growth. Furthermore, the increasing geriatric population and the push towards personalized medicine offer significant potential opportunities. Recommendation for grabbing these opportunities includes investment in R&D to enhance device connectivity and usability while strategizing market entry in emerging economies. However, limitations such as high costs, stringent regulatory approvals, and potential cybersecurity threats pose challenges to market expansion. Navigating these challenges requires clear focus on cost reduction, regulatory compliance, and robust cybersecurity measures. One area ripe for innovation and research is the integration of artificial intelligence (AI) and IoT in enhancing real-time data analytics and improving device functionality. The nature of the EDDS market is characterized by rapid technological evolution and competitive pressures, requiring constant innovation and strategic partnerships for sustained growth. In conclusion, embracing technological integration while addressing cost and regulatory challenges is pivotal for businesses aiming to achieve growth in the evolving EDDS landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 11.35 billion
Estimated Year [2024] USD 12.56 billion
Forecast Year [2030] USD 24.22 billion
CAGR (%) 11.43%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Electronic Drug Delivery System Market

The Electronic Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of target diseases
    • Favorable reimbursement scenario in major markets
    • Advancements in technologies and designs
  • Market Restraints
    • Preference for alternative drug delivery methods and the probability of errors
  • Market Opportunities
    • Increasing demand for biologics and Mabs
    • Growth opportunities in emerging markets
  • Market Challenges
    • Unfavorable reimbursement structure in developing countries

Porter's Five Forces: A Strategic Tool for Navigating the Electronic Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Electronic Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Electronic Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Electronic Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Electronic Drug Delivery System Market

A detailed market share analysis in the Electronic Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Electronic Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Electronic Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Electronic Drug Delivery System Market

A strategic analysis of the Electronic Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Electronic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include Amgen, Inc., Astrazeneca PLC, Bayer AG, Becton, Dickinson and Company, Cane SPA, Debiotech S.A., F.Hoffmann-La Roche, Ltd., Findair SP. Z O. O., Insulet Corporation, Medtronic PLC, Merck Group, Novo Nordisk A/S, Tandem Diabetes Care, Inc., United Therapeutics Corporation, and Vicentra B.V..

Market Segmentation & Coverage

This research report categorizes the Electronic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Electronic Autoinjectors, Electronic Inhalers, Electronic Injection Pens, and Electronic Wearable Infusion Pumps.
  • Based on Indication, market is studied across Asthma & COPD, Cardiovascular Disease, Diabetes, and Multiple Sclerosis.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of target diseases
      • 5.1.1.2. Favorable reimbursement scenario in major markets
      • 5.1.1.3. Advancements in technologies and designs
    • 5.1.2. Restraints
      • 5.1.2.1. Preference for alternative drug delivery methods and the probability of errors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for biologics and Mabs
      • 5.1.3.2. Growth opportunities in emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Unfavorable reimbursement structure in developing countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Electronic Drug Delivery System Market, by Type

  • 6.1. Introduction
  • 6.2. Electronic Autoinjectors
  • 6.3. Electronic Inhalers
  • 6.4. Electronic Injection Pens
  • 6.5. Electronic Wearable Infusion Pumps

7. Electronic Drug Delivery System Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma & COPD
  • 7.3. Cardiovascular Disease
  • 7.4. Diabetes
  • 7.5. Multiple Sclerosis

8. Electronic Drug Delivery System Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Electronic Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Electronic Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Electronic Drug Delivery System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen, Inc.
  • 2. Astrazeneca PLC
  • 3. Bayer AG
  • 4. Becton, Dickinson and Company
  • 5. Cane SPA
  • 6. Debiotech S.A.
  • 7. F.Hoffmann-La Roche, Ltd.
  • 8. Findair SP. Z O. O.
  • 9. Insulet Corporation
  • 10. Medtronic PLC
  • 11. Merck Group
  • 12. Novo Nordisk A/S
  • 13. Tandem Diabetes Care, Inc.
  • 14. United Therapeutics Corporation
  • 15. Vicentra B.V.

LIST OF FIGURES

  • FIGURE 1. ELECTRONIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ELECTRONIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC INJECTION PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTRONIC WEARABLE INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ASTHMA & COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ELECTRONIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. ELECTRONIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. ELECTRONIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023